LONDON, October 17, 2017 /PRNewswire/ --
Revenue Prospects for Chemistry
Services, Biology Services, Lead Optimisation, Lead Identification
and Screening, Leading National Markets and Companies
(Logo:
http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
Drug Discovery Outsourcing
- our new study reveals trends, R&D progress, and
predicted revenues
Where is the Drug Discovery Outsourcing market heading? If you
are involved in this sector you must read this newly updated
report. Visiongain's report shows you the potential revenues
streams to 2027, assessing data, trends, opportunities and business
prospects there.
Discover how to stay ahead
Our 225-page report provides 150 tables, charts, and graphs. Read
on to discover the most lucrative areas in the industry and the
future market prospects. Our new study lets you assess forecasted
sales at overall world market and regional level. See financial
results, trends, opportunities, and revenue predictions. Much
opportunity remains in this growing Drug Discovery Outsourcing
market. See how to exploit the opportunities.
Forecasts to 2027 and other analyses reveal the commercial
prospects
• In addition to revenue forecasting to 2027, our new study
provides you with recent results, growth rates, and market
shares.
• You find original analyses, with business outlooks and
developments.
• Discover qualitative analyses (including market dynamics,
drivers, opportunities, restraints and challenges), product
profiles and commercial developments.
Discover sales predictions for the world market and
submarkets
Along with revenue prediction for the overall world market, there
forecasts for 4 Drug Discovery Submarkets,
Global Drug Discovery Outsourcing Submarkets
• Chemistry Services
• Biology Services
• Lead Optimisation
• Lead Identification and Screening
In addition to the revenue predictions for the overall world
market and segments, you will also find revenue forecasts for 13
leading national markets:
• The US
• Germany
• The UK
• Italy
• Spain
• France
• Russia
• Japan
• South Korea
• China
• India
• Brazil
• Mexico
The report also includes profiles and for some of the leading
companies in the Drug Discovery Outsourcing market, with a focus on
this segment of these companies' operations.
There will be growth in both established and in developing
countries. Our analyses show that the both developed and developing
markets, India, Brazil and Mexico in particular, will continue to achieve
high revenue growth to 2027.
Leading companies and the potential for market
growth
Overall world revenue for Drug Discovery Outsourcing will surpass
$21bn in 2017, our work calculates.
We predict strong revenue growth through to 2027.
Our work identifies which organisations hold the greatest
potential. Discover their capabilities, progress, and commercial
prospects, helping you stay ahead.
How the Drug Discovery Outsourcing Market report helps
you
In summary, our 225-page report provides you with the following
knowledge:
• Revenue forecasts to 2027 for the Drug Discovery Outsourcing
market, with forecasts for 4 submarkets, each forecasted at a
global level - discover the industry's prospects, finding
the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 13 key national
markets - See forecasts for the Drug Discovery Outsourcing
market in the US, Mexico,
Brazil, Germany, France, the UK, Italy, Spain,
Russia, China, India,
Japan, and South Korea
• Discussion of what stimulates and restrains companies and the
market
• Prospects for established firms and those seeking to enter the
market - including company profiles for 10 of the major
companies involved in the Drug Discovery Outsourcing market
Find quantitative and qualitative analyses with independent
predictions. Receive information that only our report contains,
staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly updated report title, you are less likely to fall
behind in knowledge or miss out on opportunities. See how our work
could benefit your research, analyses, and decisions.
Visiongain's study is for everybody needing commercial analyses
for the Drug Discovery Outsourcing market and leading companies.
You will find data, trends and predictions.
Get our report today Drug Discovery Outsourcing Market
Forecast 2017-2027: Revenue Prospects for Chemistry Services,
Biology Services, Lead Optimisation, Lead Identification and
Screening, Leading National Markets and Companies.
To request a report overview of this report please email Sara
Peerun at sara.peerun@visiongain.com or call Tel:
+44-(0)-20-7336-6100
Or click on
https://www.visiongain.com/Report/2021/Drug-Discovery-Outsourcing-Market-Forecast-2017-2027
Companies Mentioned in the Report
AbbVie
Actavis
Acurian
Advion Bioanalytical Labs
Albany Molecular Research (AMRI)
Apredica
Aptuit
Argenta
Ark Therapeutics
Astex
AstraZeneca
Auspherix
Bayer
Behrman Capital
BGI (Beijing Genomics Institute)
BioCity
Bio Pontis Alliance
BioDuro
BioFocus
Boehringer Ingelheim
Bristol Myers Squibb
Cantab
Caprion Proteomics
Carlyle Group
Catalent
ChanTest
Charles River Laboratories
CHDI
CHDI Foundation
CONBA
Covance
Cyprotex
Domainex
Elan
Eli Lilly
Evotec
Exquiron Biotech
Forma Therapeutics
Galapagos
Genentech
GenScript
GlaxoSmithKline
Great Lakes Chemical Corp
Horizon
Hypha Discovery
IMI
Janssen Pharmaceutical
JingXin
Johnson & Johnson
Kellogg Company
Keucept
Knopp Biosciences
Laboratory Corporation of America
Laurus Labs
MedImmune
Merck
Next CODE Health
Parexel
Pharmaceutical Product Development (PPD)
Ono
Proteros Biostructures
Quintile
Roche
Sanofi
Selcia
Shionogi
Siena Biotech
The Babraham Institute
UCB
Viva Biotech
Vivo Path
WIL Research Laboratories
WuXi AppTec
WuXi PharmaTech
To see a report overview please email Sara Peerun on
sara.peerun@visiongain.com